Elsevier

Neuroscience

Volume 54, Issue 3, June 1993, Pages 691-699
Neuroscience

Serotoninergic terminal transporters are differentially affected in Parkinson's disease and progressive supranuclear palsy: An autoradiographic study with [3H]citalopram

https://doi.org/10.1016/0306-4522(93)90240-GGet rights and content

Abstract

Receptor autoradiography with [3H]citalopram as ligand was used to study the distribution of serotonin uptake binding sites in post mortem brain tissues from patients with Parkinson's disease, progressive supranuclear palsy and from age-matched controls. Significant decreases in [3H]citalopram binding sites were found in the cerebral cortex of patients with Parkinson's disease and progressive supranuclear palsy. Densities of [3H]citalopram binding sites were significantly reduced in all components of the basal ganglia of Parkinson's disease but only in the head of caudate nucleus of progressive supranuclear palsy patients. The density of [3H]citalopram binding sites in the raphe nuclei of Parkinson's disease was comparable to control values.

Our results suggest that serotoninergic terminals are differentially affected in Parkinson's disease and in progressive supranuclear palsy.

Reference (60)

  • OlpeH.R. et al.

    The response of striatal cells upon stimulation of the dorsal and median raphe nuclei

    Brain Res.

    (1977)
  • PiflCh. et al.

    Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey

    Neuroscience

    (1991)
  • ScattonB. et al.

    Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease

    Brain Res.

    (1983)
  • SoubriéP. et al.

    Functional aspects of serotonin transmission in the basal ganglia: a review and an in vivo approach using push-pull cannula technique

    Neuroscience

    (1984)
  • TörkI. et al.

    Raphe nuclei and the serotonergic system

  • WaeberC. et al.

    Serotonin 1 receptor binding sites in the human basal ganglia are decreased in Huntington's chorea but not in Parkinson's disease: a quantitative in vitro autoradiographic study

    Neuroscience

    (1989)
  • AgidY. et al.

    Progressive supranuclear palsy: anatomoclinical and biochemical considerations

  • AzmitiaE.C. et al.

    An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat

    J. comp. Neurol.

    (1978)
  • BattagliaG. et al.

    3,4-Methylendioxymethamphetamine (MDMA) and 3,4-methylendioxyamphetamine (MDA) preferentially destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of3H-paroxetine-labeled serotonin uptake sites

    J. Pharmac. exp. Ther.

    (1987)
  • BernheimerM. et al.

    Verteilung des 5-hydroxytryptamins (Serotonin) im Gehirn des Menschen und sein Verhalten bei Patienten mit Parkinson-Syndrom

    Klin. Wschr.

    (1961)
  • BirkmayerW. et al.

    Serotonin and extrapyramidal disorders

  • BlakelyR.D. et al.

    Cloning and expression of a functional serotonin transporter from rat brain

    Nature

    (1991)
  • BlierP. et al.

    Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression

    J. clin. Psychopharmac.

    (1987)
  • BrooksD.J. et al.

    Differing patterns of striatal18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy

    Ann. Neurol.

    (1990)
  • CrossA.J.

    Serotonin in neurodegenerative disorders

  • D'AmatoR.J. et al.

    Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine

    J. Pharmac. exp. Ther.

    (1987)
  • D'AmatoR.J. et al.

    Aminergic systems in Alzheimer's disease and Parkinson's disease

    Ann. Neurol.

    (1987)
  • DeArmondS.J. et al.

    Structure of the Human Brain: a Photographic Atlas

  • DrayA.

    Serotonin in the basal ganglia: functions and interactions with other neuronal pathways

    J. Physiol.

    (1981)
  • GibbW.R.G.

    Neuropathology in movement disorders

    J. Neurol. Neurosurg. Psvchiat.

    (1989)
  • Cited by (0)

    Present address: Clinica Neurologica I

    View full text